东方证券承销保荐有限公司 （一）募集资金金额及到位时间 按照中国证券监督管理委员会《关于同意海能未来技术集团股份有限公司向 不特定合格投资者公开发行股票注册的批复》（证监许可〔2022〕2023 号），并经 北京证券交易所同意，本公司向不特定合格投资者公开发行人民币普通股股票 10,000,000.00 股，每股面值 1.00 元，发行价格为人民币 10.88 元/股。本次发行募 集资金总额为人民币 108,800,000.00 元，扣除前期尚未支付的承销费用含税金额 7,630,134.40 元（不含税金额为 7,198,240.00 元）后的余额 101,169,865.60 元，已于 2022 年 9 月 29 日由东方证券承销保荐有限公司（以下简称"东方投行"）汇入本 公司在招商银行股份有限公司济南分行（以下简称"招商银行济南分行"）开立的 1 关于海能未来技术集团股份有限公司 2023 年度募集资金存放与使用情况的专项核查报告 东方证券承销保荐有限公司（以下简称"本保荐机构"或"东方投行"）作为 海能未来技术集团股份有限公司（以下简称"海能技术"或"公司"）向不特定合 格投资者公开发行股票并在北京证 ...

证券代码：430476 证券简称：海能技术 公告编号：2024-023 海能未来技术集团股份有限公司 2023 年度独立董事述职报告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 本人孙怀玉作为海能未来技术集团股份有限公司（以下简称"公司"）的独 立董事，在任职期间严格按照《公司法》、《公司章程》、《上市公司独立董事管理 办法》、《北京证券交易所上市公司持续监管指引第 1 号——独立董事》的规定， 认真、勤勉、谨慎履行职责，对公司与控股股东、实际控制人、董监高之间的潜 在重大利益冲突事项进行监督，为董事会提供多元化视角和专业支持，促进董事 会作出科学合理判断。现就 2023 年度履行独立董事职责情况汇报如下： 一、 会议出席情况 （一）出席董事会、股东大会的情况 2023 年度，公司共召开 10 次董事会会议、4 次股东大会。本人出席上述会 议的情况如下： | 出席董事 | 出席董事会 | 委托出席 董事会次 | 缺席董事 会次数 | 出席股东 | 出席股东大 | 现场工作 | | --- | --- ...

海能未来技术集团股份有限公司 董事会关于独立董事独立性情况的专项意见 （三）独立董事及其配偶、父母、子女不是直接或间接持有公司已发行股份 百分之五以上的股东，未在公司前五名股东任职； 证券代码：430476 证券简称：海能技术 公告编号：2024-024 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 根据中国证券监督管理委员会《上市公司独立董事管理办法》等相关规定， 海能未来技术集团股份有限公司（以下简称"公司"）董事会就公司在任独立董 事朱险峰、孙怀玉、单英明的独立性情况进行评估并出具了专项意见。 根据独立董事向董事会提供的关于独立性情况的自查报告，结合其他相关资 料，董事会就独立董事的独立性形成如下结论： （一）独立董事及其配偶、父母、子女、具有主要社会关系的人员未在公司 或公司附属企业任职； （二）独立董事及其配偶、父母、子女未直接或间接持有公司已发行股份百 分之一以上，不是公司前十名股东中的自然人股东； （七）独立董事最近十二个月内未曾经具有第一项至第六项所列举情形； （八）独立董事不是法律、 ...

证券代码：430476 证券简称：海能技术 公告编号：2024-021 海能未来技术集团股份有限公司 2023 年度独立董事述职报告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 本人朱险峰作为海能未来技术集团股份有限公司（以下简称"公司"）的独 立董事，在任职期间严格按照《公司法》、《公司章程》、《上市公司独立董事管理 办法》、《北京证券交易所上市公司持续监管指引第 1 号——独立董事》的规定， 认真、勤勉、谨慎履行职责，对公司与控股股东、实际控制人、董监高之间的潜 在重大利益冲突事项进行监督，为董事会提供多元化视角和专业支持，促进董事 会作出科学合理判断。现就 2023 年度履行独立董事职责情况汇报如下： 一、 会议出席情况 （一）出席董事会、股东大会的情况 2023 年度，公司共召开 10 次董事会会议、4 次股东大会。本人出席上述会 议的情况如下： | 出席董事 | 出席董事会 | 委托出席 董事会次 | 缺席董事 会次数 | 出席股东 | 出席股东大 | 现场工作 | | --- | --- ...

证券代码：430476 证券简称：海能技术 公告编号：2024-033 海能未来技术集团股份有限公司 拟续聘 2024 年度会计师事务所公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 涉及会计师事务所提供的资料、信息，会计师事务所保证其提供、报送或披 露的资料、信息真实、准确、完整，不得有虚假记载、误导性陈述或者重大遗漏。 重要内容提示： 拟聘任的会计师事务所：信永中和会计师事务所（特殊普通合伙） 服务及收费情况：信永中和会计师事务所（特殊普通合伙）已为公司提供 4 年审计服务，上期审计收费 65 万元，本期审计收费未确定 一、拟续聘会计师事务所的基本情况 （一）机构信息 公司拟聘任信永中和会计师事务所（特殊普通合伙）（以下简称"信永中和"） 为 2024 年年度的审计机构。 2022 年审计业务收入（经审计）：29.34 亿元 1. 基本信息 会计师事务所名称：信永中和会计师事务所（特殊普通合伙） 成立日期：2012 年 3 月 2 日 组织形式：特殊普通合伙 注册地址：北京市东城区朝阳门北大街 ...

证券代码：430476 证券简称：海能技术 公告编号：2024-015 海能未来技术集团股份有限公司 第四届董事会第二十三次会议决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 （一）会议召开情况 1.会议召开时间：2024 年 3 月 7 日 2.会议召开地点：山东省德州市临邑县花园东大街 16 号公司会议室 3.会议召开方式：现场结合通讯方式 4.发出董事会会议通知的时间和方式：2024 年 2 月 26 日以书面和电子邮件 方式发出 5.会议主持人：董事长王志刚先生 6.会议列席人员：监事、高级管理人员 7.召开情况合法、合规、合章程性说明： 本次会议的召集、召开、议案审议程序等符合有关法律、行政法规、部门规 章、规范性文件和《公司章程》的规定。 （二）会议出席情况 会议应出席董事 9 人，出席和授权出席董事 9 人。 董事刘文玉、徐渊、朱险峰、孙怀玉、单英明因外地办公以通讯方式参与表 决。 二、议案审议情况 （一）审议通过《关于 2023 年年度报告及摘要的议案》 ...

一、会议召开基本情况 证券代码：430476 证券简称：海能技术 公告编号：2024-035 海能未来技术集团股份有限公司 关于召开 2023 年年度股东大会通知公告（提供网络投票） 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 （一）股东大会届次 本次会议为 2023 年年度股东大会。 （二）召集人 本次股东大会的召集人为董事会。 （三）会议召开的合法性、合规性 2024 年 3 月 7 日，海能未来技术集团股份有限公司(以下简称"公司")召 开了第四届董事会第二十三次会议，会议审议通过了《关于提请召开公司 2023 年年度股东大会的议案》。本次股东大会的召开符合有关法律、行政法规、部门 规章、规范性文件和《公司章程》的规定，无需相关部门的批准或履行必要程序。 （四）会议召开方式 本次会议采用现场投票和网络投票相结合方式召开。 公司同一股东应选择现场投票、网络投票中的一种表决方式，如果同一表 决权出现重复投票表决的，以第一次投票表决结果为准。 （五）会议召开日期和时间 1、现场会议召开时间：2024 ...

证券代码：430476 证券简称：海能技术 公告编号：2024-020 海能未来技术集团股份有限公司 2023 年年度权益分派预案公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 为积极履行回报股东义务，与全体股东分享公司经营收益，在统筹考虑战略 发展目标及流动资金需求，保证公司健康、稳定、持续发展的前提下，海能未来 技术集团股份有限公司（以下简称"公司"）拟实施 2023 年年度权益分派。 一、权益分派预案情况 根据公司 2024 年 3 月 8 日披露的 2023 年年度报告（财务报告已经审计）， 截至 2023 年 12 月 31 日，上市公司合并报表归属于母公司的未分配利润为 203,952,198.45 元，母公司未分配利润为 209,335,027.54 元。 公司本次权益分派预案如下：公司目前总股本为 84,579,800 股，以未分配利 润向全体股东每 10 股派发现金红利 2.00 元（含税）。本次权益分派共预计派发 现金红利 16,915,960.00 元。 公司将以权益分派实施 ...

Financial Performance - The company's operating revenue for 2023 reached ¥341,158,171.68, representing an increase of 18.72% compared to ¥287,368,494.44 in 2022[29]. - The net profit attributable to shareholders for 2023 was ¥45,063,445.88, a slight increase of 1.40% from ¥44,443,336.72 in 2022[29]. - The total assets at the end of 2023 amounted to ¥612,746,043.99, reflecting a growth of 1.52% from ¥603,592,729.44 at the end of 2022[30]. - The total liabilities decreased by 3.10% to ¥105,913,049.37 in 2023 from ¥109,300,685.24 in 2022[30]. - The company's net asset attributable to shareholders increased by 2.77% to ¥502,038,567.75 in 2023 from ¥488,507,501.31 in 2022[30]. - The basic earnings per share for 2023 was reported at 0.54, down 10.00% from 0.60 in 2022[29]. - The cash flow from operating activities for 2023 was ¥46,144,855.38, a decrease of 34.12% compared to ¥70,044,668.58 in 2022[30]. - The gross profit margin for 2023 was 68.14%, slightly down from 69.26% in 2022[29]. - The company achieved a receivables turnover rate of 22.39 in 2023, an improvement from 20.73 in 2022[30]. - The company reported a comprehensive income of approximately 40.05 million, compared to 40.04 million in the previous year, indicating stable financial performance[38]. Research and Development - The company has maintained a research and development investment ratio exceeding 13% of its revenue for six consecutive years, indicating a strong commitment to innovation[43]. - The company has obtained a total of 29 invention patents and 110 utility model patents, showcasing its focus on proprietary technology development[43]. - R&D expenses reached 55.23 million yuan, accounting for 16.19% of operating revenue, and increased by 23.16% year-on-year[52]. - The company is actively investing in the development of near-infrared spectroscopy products, which are currently in the R&D phase[106]. - The company is developing the K2025 project, which includes a four-component low-pressure gradient infusion pump and a diode array detector, aimed at enhancing the performance and reliability of high-efficiency liquid chromatography instruments[114]. - The company has achieved significant progress in developing a dietary fiber testing instrument, focusing on automation and reliability improvements[115]. - The company aims to enhance its research and development capabilities to compete with international brands in the high-end market segment[69]. Product Development and Innovation - The company completed the development of the "Organic Element Analyzer" and successfully transitioned it to production as part of a provincial key research and development project[5]. - The company launched a new SO2 residue determination instrument compliant with the new national standards[5]. - The company has completed the prototype of a high-temperature and high-pressure microwave digestion system[5]. - The company has successfully integrated the TANK series microwave digestion technology platform, resulting in a product matrix of six rotor types[5]. - The company is focused on continuous improvement in product reliability and has completed the development of a new sulfur residue measurement instrument[53]. - The company is developing a fully automated titrator with multiple testing functions, including a Karl Fischer moisture analyzer, which is currently in the production transition phase[115]. - The company is working on a new microwave sample preparation platform, with hardware and software systems under development to enhance high-temperature and high-pressure capabilities[115]. Market Expansion and Sales - The company expanded its sales and service network across more than 20 provinces in China, enhancing customer support and market coverage[49]. - The company is actively pursuing market expansion through participation in industry exhibitions and enhancing brand recognition[57]. - The company has expanded its product applications in various sectors, including pet food, pre-prepared dishes, new energy, pharmaceuticals, vocational education, and materials analysis, contributing to sustained revenue growth[59][60][61][62][63]. - The company's overseas revenue reached 62.72 million yuan in 2023, marking a significant year-on-year growth of 87.97% due to enhanced product reliability and strategic partnerships[64]. - The revenue from the Wukong high-performance liquid chromatograph increased by 73.55% year-on-year, contributing significantly to the overall revenue growth[58]. Corporate Governance and Shareholder Relations - The company has a structured decision-making process for profit distribution, including reviews by the supervisory board and communication with minority shareholders[186]. - The board of directors includes 9 members, with a mix of executive and independent directors, ensuring diverse oversight[191]. - The total pre-tax remuneration paid to directors, supervisors, and senior management during the reporting period amounted to 10.7053 million yuan[197]. - The company has not proposed a cash dividend distribution plan for the reporting period despite having positive undistributed profits[190]. - The company emphasizes a stable profit distribution policy, ensuring reasonable returns for investors while considering long-term interests[183]. Strategic Initiatives and Future Plans - The company aims to establish a smart manufacturing lighthouse factory in collaboration with leading software and manufacturing solution providers starting in 2024[6]. - The company plans to enhance R&D investment to improve product reliability and market competitiveness in response to supportive government policies[77]. - The company aims to enhance revenue scale and market share in 2024, focusing on core business and increasing R&D and market investments[136]. - The company intends to optimize the supplier structure to reduce external procurement costs and improve delivery timeliness and acceptance rates[138]. - The company plans to continue expanding its product matrix and market reach, which is expected to positively impact future financial performance[106]. Industry Context and Trends - The global scientific instrument market is projected to reach $102 billion by 2026, a 48% increase from 2021[126]. - The scientific instrument industry is characterized by high technical barriers and a wide range of applications across sectors such as food, pharmaceuticals, and environmental monitoring[68]. - The government has allocated over CNY 3 billion for soil pollution prevention efforts in 2023, which will drive demand for analytical instruments[71]. - The scientific instrument industry is expected to benefit from ongoing government support for equipment upgrades and green procurement policies[72]. - The domestic scientific instrument manufacturers generally lack scale and brand recognition compared to international competitors, indicating significant room for growth in domestic market share[69].

Financial Performance - The company achieved operating revenue of CNY 341,158,171.68, representing an 18.72% increase compared to the previous year[4] - Net profit attributable to shareholders of the listed company was CNY 45,063,445.88, a 1.40% increase year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 37,006,883.29, reflecting a 5.26% growth compared to the previous year[4] - Basic earnings per share decreased by 10.00% to CNY 0.54 from CNY 0.60 in the previous year[4] Assets and Equity - Total assets at the end of the reporting period were CNY 612,746,043.99, up 1.52% from the beginning of the period[5] - Shareholders' equity attributable to the listed company increased by 2.77% to CNY 502,038,567.75[5] Market and Product Development - The company focused on enhancing operating revenue and market share, leading to significant growth in various product segments, particularly in high-efficiency liquid chromatography instruments[7] - Continuous investment in R&D and market efforts contributed to revenue growth across all four product series, with notable acceptance in both domestic and international markets[7] - The company emphasized sustainable development through improvements in products, technology, and user experience, resulting in increased R&D and marketing expenses[8] Financial Data Disclaimer - Investors are advised that the financial data presented are preliminary and unaudited, with final figures to be disclosed in the annual report[9]